HOME >> BIOLOGY >> NEWS
First time in the U.S.: Saint Louis University tests third-generation vaccine against smallpox

ST. LOUIS - Not everybody can safely be vaccinated against smallpox using the current FDA-approved vaccine. Scientists hope another study vaccine, now undergoing its first testing in the United States at Saint Louis University, will give a choice to people who can't be given the current vaccine, known as Dryvax.

"There are limits to the current vaccine," said Sharon Frey, M.D., from Saint Louis University's Center for Vaccine Development. "You can't give Dryvax to people with certain skin conditions, such as eczema, or to people who are immunosuppressed. So, for example, if you are HIV-positive or undergoing chemotherapy for cancer, you shouldn't receive the currently licensed vaccine."

Dr. Frey said this study vaccine, known as MVA-BN and provided through Bavarian Nordic, is different than other vaccines that are now available. Like the current vaccines, the study vaccine is a live-virus vaccine made from vaccinia virus, but this study vaccine contains a much more "attenuated," or weakened, form of the virus.

"The thinking is that the study vaccine is much more attenuated, therefore the side effects should be less. So the hope is you may be able to give it to someone who is immunosuppressed. These are some of the questions we'll be studying as we start testing this investigational drug. If our studies prove successful, we hope this vaccine can be given to people for whom Dryvax is contraindicated."

MVA-BN also is administered in a different way. Dryvax is administered using a method called scarification, in which the skin is poked with a bifurcated needle just enough to puncture the skin. The study vaccine being tested will be administered intramuscularly, as a flu shot is given, or subcutaneously between the skin and muscle, as an insulin shot is given.

The study will enroll 90 adult volunteers into six different groups. MVA-BN will be given in three different dose strengths alone or in combination with Dryvax. The study i
'"/>

Contact: Joe Muehlenkamp
muehlenk@slu.edu
314-977-8015
Saint Louis University
10-May-2004


Page: 1 2

Related biology news :

1. First glimpse of DNA binding to viral enzyme
2. First clinical study of new pediatric croup vaccine shows safety, tolerability in adults
3. 2nd media alert First Scientific Conference on Childhood Leukaemia
4. First International Scientific Conference on Childhood Leukaemia
5. First ever standards linking climate change, biodiversity and poverty seek global peer review
6. First genetic comparison of purebred domestic dogs produces surprises
7. First target for childhood malaria vaccine
8. First study of resveratrol dietary supplement finds effect on breast and prostate cancers unlikely
9. First flavors form a lasting impression
10. STN International launches Derwent World Patents Index First View
11. First DFG research conference in the USA

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/7/2018)... ... November 07, 2018 , ... ... advisory firm serving the life science industry. The event was attended by 150 ... that advance biological research and drug discovery. The winners were determined by responses ...
(Date:11/6/2018)... (PRWEB) , ... November 06, 2018 , ... ... R&D, today announced that Sartorius Stedim Cellca GmbH, a subsidiary of Sartorius Stedim ... large-scale protein production, has licensed the Genedata Bioprocess ® enterprise platform to ...
(Date:11/3/2018)... ... November 01, 2018 , ... Karius , the leading infectious disease ... study human pathogens in pediatric patients. One grant of up to $50,000 will be ... test for infectious diseases. In addition to the funding, Karius will cover the cost ...
Breaking Biology News(10 mins):
(Date:11/9/2018)... SAN FRANCISCO (PRWEB) , ... November 08, 2018 ... ... addition of Dr. Pablo Valenzuela, PhD, co-Founder, Chief Executive Officer and President of ... and doctors from around the world, Dr. Valenzuela brings to uBiome expertise on ...
(Date:11/6/2018)... TAHOE, Nev. (PRWEB) , ... November 06, 2018 ... ... their native mobile app for clinical trial data collection and management. TrialKit ... iPhone users with compatible generation devices can quickly and easily sign in to ...
(Date:11/3/2018)... ... November 01, 2018 , ... Come to Princeton Nov. ... Senior Advisor, Division of Clinical Compliance Evaluation, CDER, FDA will be presenting on ... , What should clinical research industry stakeholders keep in mind when implementing and ...
(Date:10/31/2018)... , ... October 30, 2018 , ... ... continue to be a very important aspect of experimental biology. Reproducibility of cell-based ... experimental data. Despite of choosing the appropriate assay type, there are many more ...
Breaking Biology Technology:
Cached News: